Lung Cancer Drug, Nivolumab (Opdivo), Targets 'Hidden' HIV in French Patient

FRIDAY, Dec. 1, 2017 — In a case that investigators say is a first, a lung cancer drug unmasked and then attacked the kind of HIV-infected cells that standard antiretroviral therapy has been unable to touch.
The finding was reported on Dec. 1,…
Source: Topamax